Computational analyses to reveal the key determinants of the high malignancy level of cholangiocarcinoma
BAs are the key contributors to the lowest five-year survival rate of CHOL among the seven cancer types studied here. This finding not only reveals the molecular mechanisms underlying the high malignancy level of CHOL but also provides a new potential target for the diagnosis and treatment of CHOL.
Authors
- Zhenyu Huang (ORCID: https://orcid.org/0009-0009-0029-1729)
- Yinwei Qu
- Aoran Liu (ORCID: https://orcid.org/0000-0002-0443-5605)
- Xuan Li (ORCID: https://orcid.org/0009-0007-6853-5668)
- Jun Xiao (ORCID: https://orcid.org/0009-0007-6966-4437)
- Ying Xu (ORCID: https://orcid.org/0009-0004-8767-7635)
- Xuechen Mu (ORCID: https://orcid.org/0000-0003-1006-2830)
- Zhang Ye (ORCID: https://orcid.org/0000-0003-3495-5596)
- Zhihang Wang
Institutions
- Jilin University (CN)
- Southern University of Science and Technology (CN)
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Journal of Translational Internal Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1515/jtim-2024-0033
- Citations
- 3
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.72
Funders
- Southern University of Science and Technology